ArticleNeurochemical research2025
P300-Mediated ARRB1 Lactylation Promotes Mitochondrial Dysfunction and Neuronal Apoptosis in Subarachnoid Hemorrhage Via Upregulating S100A9.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Hypertension Drives Protein Lactylation and Vascular Dysfunction in Skeletal Muscle.Hypertension (Dallas, Tex. : 1979) · 2026Article
- Transferrin receptor serves a role in promoting PANoptosis in thyroid cancer.Oncology letters · 2026Article
- Lactylation at the crossroads of metabolism and epigenetics in neuroinflammation.Frontiers in immunology · 2026Review
- Review
- Effects of lactylation on the hallmarks of cancer (Review).Oncology letters · 2025Review
- Lactylation in post-stroke fatigue: linking metabolic dysregulation to neuroinflammation.Frontiers in neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundLactylation, a novel lactate-derived posttranslational modification, has been demonstrated to be linked with brain function. The present research is intended to explore the role of β-arrestin1 (ARRB1) lactylation post-subarachnoid hemorrhage (SAH).
methodsSAH models were established in mice via intravascular puncture and in primary neurons by oxyhemoglobin (oxyHb) stimulation. Lactylome analysis identified differentially lactylated proteins. Commercial kits measured lactate, mitochondrial membrane potential, reactive oxygen species (ROS), and ATP. Mitochondrial respiration was evaluated by detecting mitochondrial oxygen consumption rate. Cell viability and apoptosis were respectively determined by CCK-8 assay and flow cytometry/TUNEL assay. Protein interactions were assessed using co-immunoprecipitation and double-label immunofluorescence.
resultsElevated lactate and ARRB1 lactylation were observed in the brain of SAH mice. In primary neurons, reducing lactate with oxamate reversed mitochondrial dysfunction and apoptosis induced by oxyHb. Overexpression of ARRB1 exacerbated oxyHb-induced neuronal injury, yet this effect was absent with the ARRB1-lysine (K) 195 arginine (R) mutant. E1A binding protein P300 (P300) promoted ARRB1 lactylation to upregulate its protein expression. P300 knockdown inhibited oxyHb-induced neuronal injury, but this inhibitory effect was counteracted by ARRB1 overexpression. In oxyHb-stimulated neurons, ARRB1 lactylation upregulated S100 calcium binding protein A9 (S100A9) protein. Additionally, ARRB1 knockdown prevented mitochondrial respiratory dysfunction in neurons induced by oxyHb, which was antagonized by recombinant S100A9. ARRB1 silencing mitigated SAH injury in mice via suppressing S100A9-mediated mitochondrial dysfunction.
conclusionP300 mediated ARRB1 lactylation, thereby increasing S100A9 to facilitate mitochondrial dysfunction and neuronal apoptosis in SAH. This study may provide prospective targets for improving SAH.
Indexed as
Identifiers
40445496What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.